ZELAPAR
SELEGILINE HYDROCHLORIDE
ZELAPAR is indicated as an adjunct in the management of patients with Parkinson's disease being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy.
Form
Tablet
Uses
1
Side effects
1
Category
Neurological
What is ZELAPAR used for?
- Adjunct therapy for Parkinson's disease in patients experiencing deterioration in response to levodopa/carbidopa.
SELEGILINE HYDROCHLORIDE side effects
The following side effects have been reported for SELEGILINE HYDROCHLORIDE. Their order does not indicate how often an effect occurs.
SELEGILINE HYDROCHLORIDE warnings & precautions
- The selectivity of ZELAPAR for MAO-B may not be absolute even at the recommended daily dose of 2.5 mg daily.
- The selectivity of MAO-B inhibitors typically decreases, and it is ultimately lost as the dose is increased beyond recommended doses.
Loading FDA data…
Frequently asked questions
Related medications
Share this drug info.
Help friends and family understand ZELAPAR in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.